|Bid||102.31 x 800|
|Ask||111.10 x 800|
|Day's range||107.24 - 111.02|
|52-week range||94.38 - 136.48|
|Beta (5Y monthly)||1.24|
|PE ratio (TTM)||12.93|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
DaVita (DVA) acquires MedSleuth which will help simplify the kidney transplant process and provide patients greater access to transplantation.
In this article we are going to estimate the intrinsic value of DaVita Inc. ( NYSE:DVA ) by taking the forecast future...
With stocks offering dialysis services, including DaVita (DVA), facing several issues, it would be prudent to invest in medical care and services stocks like DGX, AMN and CODX instead for 2022.